Literature DB >> 4425763

Anti-inflammatory and irritant effects of a fraction from normal human plasma.

P N Elliott, A W Ford-Hutchinson, M J Smith.   

Abstract

1 By the use of carrageenan-induced rat paw oedema assay the anti-inflammatory activity of a fraction isolated from normal human plasma has been measured after its intravenous, intraperitoneal and oral administration. Its effects in the dextran-induced rat paw oedema and the systemic dextran anaphylactoid reaction in the rat were also studied.2 The fraction showed marked anti-inflammatory activity in the carrageenan test after intravenous administration and a smaller but still significant activity when given intraperitoneally, but was inactive orally after the administration of a larger dose. It was active in the dextran-induced paw oedema test but not against the anaphylactoid reaction.3 A comparison between its anti-inflammatory and irritant properties revealed no correlation when each parameter was determined in relation to dose. The fraction did not affect the blood pressure of the anaesthetized rat.4 These findings are discussed in relation to the existence of a natural anti-inflammatory substance or substances in human plasma.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4425763      PMCID: PMC1776622          DOI: 10.1111/j.1476-5381.1974.tb08569.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.

Authors:  C A WINTER; E A RISLEY; G W NUSS
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

2.  [Inhibition of polyvinylpyrrolidone edema of the rat paw by the intraperitoneal injection of edema-producing substance].

Authors:  O BUECH; T WAGNER-JAUREGG
Journal:  Arzneimittelforschung       Date:  1962-06

3.  Reactions of albino rats to injections of dextran.

Authors:  A B VOORHEES; H J BAKER; E J PULASKI
Journal:  Proc Soc Exp Biol Med       Date:  1951-02

4.  Anti-inflammatory substance in human serum.

Authors:  J N McArthur; M J Smith; P C Freeman
Journal:  J Pharm Pharmacol       Date:  1972-08       Impact factor: 3.765

5.  Separation of irritancy from the anti-inflammatory component of inflammation exudate.

Authors:  M E Billingham; B V Robinson
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

6.  Observations on the pharmacological properties of inflammatory exudate.

Authors:  D C Atkinson; A L Boura; R Hicks
Journal:  Eur J Pharmacol       Date:  1969-12       Impact factor: 4.432

7.  Partial purification of the anti-inflammatory factor(s) in inflammatory exudate.

Authors:  M E Billingham; B V Robinson; J M Robson
Journal:  Br J Pharmacol       Date:  1969-03       Impact factor: 8.739

8.  Anti-inflammatory activity in human plasma.

Authors:  A W Ford-Hutchinson; M Y Insley; P N Elliott; E A Sturgess; M J Smith
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

9.  Mode of action of antirheumatic drugs.

Authors:  J N McArthur; P D Dawkins; M J Smith; E B Hamilton
Journal:  Br Med J       Date:  1971-06-19

10.  Relationship between the anti-inflammatory and irritant properties of inflammatory exudate.

Authors:  D C Atkinson; R Hicks
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739

  10 in total
  1 in total

1.  An anti-inflammatory substance in normal human plasma.

Authors:  M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1975-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.